0001123292-24-000137.txt : 20240516 0001123292-24-000137.hdr.sgml : 20240516 20240516112310 ACCESSION NUMBER: 0001123292-24-000137 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 EFFECTIVENESS DATE: 20240516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athyrium Capital Management, LP CENTRAL INDEX KEY: 0001728001 ORGANIZATION NAME: IRS NUMBER: 263965190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18509 FILM NUMBER: 24954057 BUSINESS ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-402-6925 MAIL ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001728001 XXXXXXXX 03-31-2024 03-31-2024 false Athyrium Capital Management, LP

505 Fifth Avenue, Floor 18 New York NY 10017

13F HOLDINGS REPORT 028-18509 000161528 801-73737 N Andrew Hyman 212-402-6925 /s/ Andrew Hyman New York NY 05-16-2024 0 3 72784577 INFORMATION TABLE 2 informationtable.xml Biora Therapeutics Inc. COM NEW 74319F305 12022739 10929762 SH SOLE 10929762 0 0 Omeros Corp NOTE 5.250% 2/1 682143AG7 54102860 72979000 PRN SOLE 0 0 72979000 PUMA BIOTECHNOLOGY INC COM 74587V107 6658978 1256411 SH SOLE 1256411 0 0